By Associate Professor Anthony John Dodds

Journal articles

Abhyankar S; Shaughnessy P; Bolwell B; van Besien K; Mistrik M; Ihan O; Grigg A; Prince HM; Dodds AJ; Machado A; Wang JQ; Thienel U; Peters C; Foss F; Apperley J, 2005, 'Extracorporeal photoimmune therapy with UVADEX for the prevention of acute graft-versus-host disease in patients undergoing standard myeloablative conditioning and allogeneic haematopoetic stem cell transplantation', Bone Marrow Transplantation, 35, pp. S132 - S132, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000228336000343&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Bai L; Deng YM; Dodds AJ; Milliken ST; Moore JJ; Ma DD, 2005, 'A SYBR green-based real time PCR method for detection of haemopoietic chimerism in allogeneic stem cell transplant recipients', Blood, 106, pp. 389B - 389B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233426102324&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Dodds AJ; Ma DD; Milliken ST; Fay K; Cunningham PH; Moore JJ, 2005, 'Cytomegalovirus viraemia after allogeneic transplant: A prospective study of a risk-adapted strategy in a single transplant unit', Blood, 106, pp. 429B - 429B, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233426102475&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Abhyankar S; Shaughnessy P; Bolwell B; van Besien K; Mistrik M; Grigg A; Dodds AJ; Prince HM; Machado A; Thienel U; Wang J; Foss F; Apperley J, 2005, 'A multi-institutional study of extracorporeal photoimmune therapy (ECP) with UVADEX (R) for the prevention of acute gvhd in patients (PTS) undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation (AHCT)', Biology of Blood and Marrow Transplantation, 11, pp. 37 - 37

Ma DD; Kovacic JC; Dodds AJ; Tao H; Mcdonald PS; Feneley MP; Muller DW; Fruend J; Milliken ST; Moore JJ; Itescu S; Graham RM, 2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, 106, pp. 134B - 134B

Nivision-Smith I; Bradstock KF; Dodds AJ; Hawkins P; Szer J, 2005, 'Haemopoietic stem cell transplanation in Australia and New Zealand, 1992-2001:Progress report from the Australasian Bone Marrow Transplant Recipient Registry', Internal Medicine Journal, 35, pp. 18 - 27

Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins P; Szer J, 2005, 'Haemopoietic stem cell transplantation in Australia and New Zealand,1992-2001: progress report from the Australasian Bone Marrow TransplantRecipient Registry', Internal Medicine Journal, 35, pp. 18 - 27

Shaughnessy PJ; Bolwell BJ; Abhyankar S; van Besien K; Mistrik M; Grigg A; Dodds A; Prince HM; Machado A; Thienel U; Wang J; Foss F; Apperley J, 2004, 'A Multi-Institutional Study of Extracorporeal Photoimmune Therapy with UVADEX® for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation.', Blood, 104, pp. 1230 - 1230, http://dx.doi.org/10.1182/blood.v104.11.1230.1230

Michallet M; Maloisel F; Delain M; Hellmann A; Rosas A; Silver RT; Tendler C; Rose E; Yeardley H; Kusminsky G; Bernhart M; Gastl G; Dodds A; Lindeman R; Boogaerts M; Debusscher L; Efira A; Rauis M; Belanger R; Bormanis J; Cantin G; Forrest D; Kovacs M; Laneuville P; Lipton JH; Lopez P; Turner R, 2004, 'Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: A phase III study', Leukemia, 18, pp. 309 - 315, http://dx.doi.org/10.1038/sj.leu.2403217

Nivison-Smith I; Ma DD; Bradstock KF; Szer J; Dodds AJ, 2004, 'Reduced-intensity allogeneic transplants: an update report from theAustralasian Bone Marrow Transplant Recipient Registry', Bone Marrow Transplantation, 33, pp. S104 - S104, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000220850900296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Shaughnessy P; Bolwell B; Abhyankar S; van Besien K; Mistrik M; Grigg A; Dodds AJ; Prince HM; Machado A; Thienel U; Wang JQ; Foss F; Apperley J, 2004, 'A multi-institutional study of extracorporeal photoimmune therapy with UVADEX (R) for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation', Blood, 104, pp. 347A - 347A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000225127501232&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Moore JJ; Bradstock K; Dodds AJ; Szer J; Smith I; Goh KE; Ma DD, 2004, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic transplantation for AML', Blood, 104, pp. 378B - 378B

Abhyankar S; Bolwell B; Shaughnessy P; van Besien K; Ilhan O; Machado A; Dodds AJ; Grigg A; Prince HM; Mistrik M; Gruben D; Thienel U, 2004, 'A multi-institutional study of extracorporeal photophoresis (ECP) withUvadex (R) for the prevention of acute graft vs. host disease (aGvHD)in patients (pts) undergoing allogeneic hematopoietic progenitor celltransplants (allo-HPCT) with myeloablative', Biology of Blood and Marrow Transplantation, 10, pp. 53 - 53

Shaughnessy P; Bolwell B; Abhyankar S; van Besien K; Mistrik M; Grigg A; Dodds AJ; Machado A; Gruben D; Thienel U, 2003, 'Extracorporeal photoimmune therapy with Uvadex (R) for the preventionof acute graft versus host disease in patients undergoing standardmyeloablative conditioning and allogeneic hematopoietic stem celltransplantation', Blood, 102, pp. 714A - 714A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186536702642&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Szer J; Bradstock K; Nivison-Smith I; Dodds A, 2003, '79 Stem cell transplantation in Australia and New Zealand: An update from the Australasian bone marrow transplant recipient registry (ABMTRR)', Biology of Blood and Marrow Transplantation, 9, pp. 88 - 88, http://dx.doi.org/10.1016/s1083-8791(03)80080-0

Greenwood MJ; Dodds AJ; Garrick R; Rodriguez M, 2003, 'Posterior Leukoencephalopathy in Association with the Tumour Lysis Syndrome in Acute Lymphoblastic Leukaemia - A case with Clinicopathological Correlation', Leukemia and Lymphoma, 44, pp. 719 - 721

Nivison-Smith I; Bradstock KF; Szer J; Durrant S; Dodds A; Hermann R; Schwarer AP; Gibson J; To LB; Arthur C, 2001, 'Allogeneic haemopoietic cell transplants in Australia, 1996 - A multicentre retrospective comparison of the use of peripheral blood stem cells with bone marrow', Bone Marrow Transplantation, 28, pp. 21 - 27, http://dx.doi.org/10.1038/sj.bmt.1703088

Matthews JP; Bishop JF; Young G; Juneja SK; Lowenthal RM; Garson OM; Cobcroft RG; Dodds AJ; Enno A; Gillett EA; Hermann RM; Joshua DE; Ma DD; Szer J; Taylor KM; Wolfe M; Bradstock KF, 2001, 'Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia', British Journal of Haematology, 113, pp. 727 - 736

Nivison-Smith I; Bradstock KF; Szer J; Durrant S; Dodds AJ; Hermann RM; Schwarer AP; Gibson JA; To LB; Arthur C, 2001, 'Peripheral blood stem cells: Allogeneic haemopoietic cell transplants in Australia, 1996 - A multicentre retrospective comparison of the use of peripheral blood stem cells with bone marrow.', Bone Marrow Transplantation, pp. 21 - 27

Kearney PP; Boutros R; Dodds AJ; Biggs JC, 2001, 'Transformation to acute leukaemia in an MDS patient harbouring bcr-abl and bcl 2-IgH rearrangements, without expression of either activated oncogene', Leukemia Research, pp. 359 - 360

Kearney PP; Boutros R; Dodds AJ; Biggs JC, 2001, 'Transformation to acute leukaemia in an MDS patient harbouring bcr-abl and bel 2-IgH rearrangements, without expression of either activated oncogene.', Leukemia Research, pp. 359 - 360

Rowlings PA; Greenstein V; Nivison-Smith I; Dodds A; Bradstock K; Szer J, 2000, 'Second allogenic transplant for leukaemia after failed first autologous transplant', Blood, 96

Snowden JA; Nivison-Smith I; Atkinson K; Fay K; Concannon A; Dodds A; Milliken S; Biggs J, 2000, 'Allogeneic PBPC transplantation: An effect on incidence and distribution of chronic graft-versus-host disease without long-term survival benefit?', Bone Marrow Transplantation, 25, pp. 119 - 120, http://dx.doi.org/10.1038/sj.bmt.1702090

Grigg A; Szer J; Beresford J; Dodds AJ; Bradstock KF; Durrant S; Schwarer AP; Hughes T; Herrmann RP; Gibson K; Arthur C; Matthews JP, 1999, 'Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia', British Journal of Haematology, 107, pp. 409 - 418

Trotman J; Nivison-Smith I; Dodds AJ, 1999, 'Haemorrhagic Cystitis: incidence and risk factors in a transplant population using hyperhydration', Bone Marrow Transplantation, pp. 797 - 801

Atkinson K; Nivison-Smith I; Dodds AJ; Concannon A; Milliken ST; Downs KR, 1998, 'A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989', Bone Marrow Transplantation, pp. 691 - 695

Atkinson K; Nivison-Smith I; Dodds AJ; Concannon A; Milliken ST; Downs KR, 1998, 'A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989.', Bone Marrow Transplantation, pp. 691 - 695

Dodds AJ; Nivison-Smith I; Milliken ST; Concannon AJ; Fay K; Biggs JC, 1997, 'Haemorrhagic cystitis - A manifestation of graft-versushost disease?', Experimental Hematology, 25, pp. 823

Presgrave PJ; Milliken SM; Concannon AJ; Biggs JC; Atkinson K; NivisonSmith I; Dodds AJ, 1997, 'Reduced morbidity and mortality in autologous bone marrow transplantation: The role of prophylactic fluconazole, norfloxacin and heparin.', BLOOD, 90, pp. 4430 - 4430, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997YG42501739&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dodds AJ; NivisonSmith I; Milliken ST; Concannon AJ; Fay K; Biggs JC, 1997, 'Haemorrhagic cystitis - A manifestation of graft-versus-host disease?', EXPERIMENTAL HEMATOLOGY, 25, pp. 329 - 329, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XR33000319&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Morton J; Taylor K; Bunce I; Eliadis P; Rentoul A; Moore D; Kelly C; Wright S; Bashford J; Rodwell R; Rooney K; Mulligan S; Firkin F; Dodds A; Parkin J; Lowenthal R; Kimber R; Frost T; Grigg A; Goldstein D; Stone J; Lee N, 1996, 'High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma', British Journal of Haematology, 95, pp. 110 - 115, http://dx.doi.org/10.1046/j.1365-2141.1996.d01-1868.x

Wolfe M; Kronenberg H; Dodds AJ; Miach P; Isbister J; Levidiotis M; Dear K, 1996, 'A safety study of Albumex 5, a human albumin solution plroduced byion exchange chromatography', Vox Sanguinis, pp. 198 - 202

Wolf M; Kronenberg H; Dodds A; Miach P; Isbister J; Levidiotis M; Dear K, 1996, 'A Safety Study of Albumex® 5, a Human Albumin Solution Produced by Ion Exchange Chromatography', Vox Sanguinis, 70, pp. 198 - 202, http://dx.doi.org/10.1159/000462115

Atkinson K; Downs KR; Dodds AJ; Concannon A; Milliken ST, 1996, 'Five year leukaemia free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation', Australian and New Zealand Journal of Medicine, pp. 54 - 58

PRESGRAVE PJ; DODDS AJ; CONCANNON AJ; MILLIKEN SM; ATKINSON K; DOWNS K; HARKNESS J; BIGGS JC, 1995, 'REDUCED MORBIDITY AND MORTALITY ASSOCIATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - IMPROVED RESULTS WITH FLUCONAZOLE, NORFLOXACIN AND HEPARIN', EXPERIMENTAL HEMATOLOGY, 23, pp. 857 - 857, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995RP11600398&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Biggs J; Atkinson K; Booker V; Concannon A; Dart GW; Dodds AJ; Downs KR; Szer J; Turner J; Worthington R, 1995, 'A prospective randomised double blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA identical sibling donors', Bone Marrow Transplantation, 15, pp. 129 - 134

Atkinson K; Dodds AJ; Milliken ST; Concannon A; Fay K; Harris MF; Flecknoe-Brown S; Lind D; Mckinley R; Rutovitz J; Rosenfeld D; Harvey M; Downs KR; Flattery D; Song JY; Green AR; Quigley V; Hawkins T, 1995, 'Autologus blood stem cell transplantation for haematological malignancy: treatment-related mortality of 2%', Australian and New Zealand Journal of Medicine, pp. 483 - 489

Berger MT; Boyle MJ; Valentine JE; Dodds AJ; Penny R; Sewell WA; boyle , 1995, 'Expression of cytokine genes in T cell leukaemias', Pathology, pp. 347 - 351

Atkinson K; Bartlett A; Dodds A; Rallings M, 1994, 'Lack of efficacy of a short ex vivo incubation of human allogeneic donor marrow with recombinant human GM-CSF prior to its infusion into the recipient', Bone Marrow Transplantation, 14, pp. 573 - 577

BRADSTOCK K; MATTHEWS J; BENSON E; PAGE F; BISHOP J; PIDCOCK M; GALLO J; ROSENFELD D; KWAN Y; TANG RLP; ENNO A; SELDON N; GIBSON J; ILAND K; JOSHUA D; KRONENBERG H; VINCENT P; YOUNG G; MANOHARAN A; ATKINSON K; BIGGS J; CONCANNON A; DODDS A; BENSON W; GOTTLIEB D; KOUTTS J; LEE C; TAYLOR K; COBCROFT R; GILL D; BUNCE I; DURRANT S; GILLETT A; HILL G; ROESSER P; ROONEY K; KIMBER R; LOWENTHAL R; DALE B; JUTTNER C; FIRKIN B; SZER J; VANDERWEYDEN M; WHITESIDE M; COOPER I; DING J; JANUSZEWICZ E; WOLF M; FOX R; GREEN M; FIRKIN F; LEAHY M; HERRMANN R, 1994, 'PROGNOSTIC VALUE OF IMMUNOPHENOTYPING IN ACUTE MYELOID-LEUKEMIA', BLOOD, 84, pp. 1220 - 1225, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994PC40200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bishop JF; Matthews JP; Young G; Szer J; Joshua DE; Dodds A; Laidlaw CR; Cobcroft R; Herrman R; Ma D; Page FJ, 1994, 'The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia', Leukemia and Lymphoma, 15, pp. 79 - 84, http://dx.doi.org/10.3109/10428199409051681

Atkinson K; Marshall G; Biggs JC; Wilson F; Concannon AJ; Young S; Dodds AJ; Ashby M; Milliken S; Morgan G; Downs K; Harkness J, 1993, 'Changing results of HLA‐identical sibling bone marrow transplantation in patients with haematological malignancy during the period 1981–1990', Australian and New Zealand Journal of Medicine, 23, pp. 181 - 186, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01814.x

Brodsky I; Biggs JC; Szer J; Crilley P; Atkinson K; Downs K; Dodds A; Concannon AJ; Avalos BR; Tutschka P; Kapoor N; Topolsky D; Bulova SI; Copelan EA, 1993, 'Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): An update', Seminars in Oncology, 20, pp. 27 - 31

Atkinson K; Downs K; Dodds AJ; Marshall G; Concannon AJ; Wilson F; Milliken S; Staniforth D, 1993, 'Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney', Australian and New Zealand Journal of Medicine, 23, pp. 450 - 457, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01829.x

Biggs JC; Szer J; Crilley P; Atkinson K; Downs K; Dodds A; Concannon AJ; Avalos B; Tutschka P; Kapoor N; Brodsky I; Topolsky D; Bulova SI; Copelan EA, 1992, 'Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2', Blood, 80, pp. 1352 - 1357

Biggs JC; Szer J; Crilley P; Atkinson K; Downs K; Dodds A; Concannon AJ; Avalos B; Tutschka P; Kapoor N, 1992, 'Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2', Blood, 80, pp. 1352 - 1357, http://dx.doi.org/10.1182/blood.v80.5.1352.bloodjournal8051352

ATKINSON K; BARTLETT A; DODDS A; BIGGS J, 1992, 'EXVIVO INCUBATION OF HUMAN ALLOGENEIC DONOR MARROW WITH RECOMBINANT HUMAN GM-CSF PRIOR TO ITS INFUSION INTO THE RECIPIENT', EXPERIMENTAL HEMATOLOGY, 20, pp. 770 - 770, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992JA73400251&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Morgan MJ; Dodds AJ; Wolf M; Januszewicz H; Ma D; Downs K; Cooper I, 1992, 'High dose chemotherapy and autologous bone marrow transplantation in advanced Hodgkin's disease', Medical Journal of Australia, 157, pp. 527 - 530, http://dx.doi.org/10.5694/j.1326-5377.1992.tb137348.x

ATKINSON K; DOWNS K; GOLENIA M; BIGGS J; MARSHALL G; DODDS A; CONCANNON A, 1991, 'ERADICATION OF CLINICAL CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH THE USE OF PROPHYLACTIC GANCICLOVIR', EXPERIMENTAL HEMATOLOGY, 19, pp. 578 - 578, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991FQ31000456&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

ATKINSON K; BIGGS JC; DOWNS K; DODDS A; CONCANNON A, 1991, 'IMPROVING RESULTS OF HLA-IDENTICAL SIBLING MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCY DURING THE PERIOD 1981-1990', EXPERIMENTAL HEMATOLOGY, 19, pp. 578 - 578, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991FQ31000457&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page